✦ LIBER ✦

ChemInform Abstract: Novel Agents Combining Platelet Activating Factor (PAF) Receptor Antagonist with Thromboxane Synthase Inhibitor (TxSI).

✍ Scribed by Masakazu Fujita; Taketsugu Seki; Haruaki Inada; Kazuhiro Shimizu; Akane Takahama; Tetsuro Sano

Publisher: John Wiley and Sons
Year: 2010
Weight: 30 KB
Volume: 33
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200225219

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Syntheses and Bioac

ChemInform Abstract: Syntheses and Bioactivities of Novel Carbamates Combining Platelet Activating Factor (PAF) Receptor Antagonist with Thromboxane Synthase Inhibitor (TxSI).

✍ Masakazu Fujita; Taketsugu Seki 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

Basic pharmacophore of some antithrombot

Basic pharmacophore of some antithrombotic agents with combined thromboxane receptor antagonist (TxRA)/thromboxane synthase inhibitor (TxSI) activity

✍ Yang Jie; Hua Weiyi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Platelet activation, causing formation of platelet aggregates, plays a major role in occlusive thrombus formation which may induce ischemic cardiovascular diseases. Thromboxane A2 (TXA2) is an extremely potent vasoconstricting and platelet-aggregating agent so that it is important to search for a ne